Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction 22 - PROVE IT/TIMI 22—Lipid Lowering Results


The goal of the PROVE IT/TIMI 22 trial was to evaluate the efficacy of standard lipid lowering with pravastatin compared with aggressive lipid lowering using atorvastatin in patients hospitalized for an acute coronary syndrome (ACS).